Cohort | Description | Corr | P value |
---|---|---|---|
PRAD | Prostate adenocarcinoma | 0.644 | 1.58E-59 |
KICH | Kidney Chromophobe | 0.590 | 1.88E-07 |
PAAD | Pancreatic adenocarcinoma | 0.517 | 1.41E-13 |
SARC | Sarcoma | 0.503 | 5.22E-18 |
GBMLGG | Glioma | 0.501 | 9.73E-44 |
THYM | Thymoma | 0.462 | 1.07E-07 |
LUAD | Lung adenocarcinoma | 0.448 | 8.68E-27 |
THCA | Thyroid carcinoma | 0.445 | 1.00E-25 |
KIPAN | Pan-kidney cohort (KICH+KIRC+KIRP) | 0.431 | 1.30E-41 |
KIRP | Kidney renal papillary cell carcinoma | 0.431 | 1.48E-14 |
STES | Stomach and Esophageal carcinoma | 0.415 | 2.24E-26 |
STAD | Stomach adenocarcinoma | 0.412 | 1.77E-18 |
ESCA | Esophageal carcinoma | 0.398 | 2.28E-08 |
KIRC | Kidney renal clear cell carcinoma | 0.392 | 5.52E-21 |
CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | 0.380 | 7.13E-12 |
UCEC | Uterine Corpus Endometrial Carcinoma | 0.369 | 4.73E-19 |
LIHC | Liver hepatocellular carcinoma | 0.348 | 5.09E-12 |
COAD | Colon adenocarcinoma | 0.344 | 3.87E-14 |
GBM | Glioblastoma multiforme | 0.306 | 1.17E-04 |
COADREAD | Colorectal adenocarcinoma | 0.291 | 1.25E-13 |
BRCA | Breast invasive carcinoma | 0.282 | 1.74E-21 |
SKCM | Skin Cutaneous Melanoma | 0.270 | 5.76E-03 |
HNSC | Head and Neck squamous cell carcinoma | 0.264 | 1.04E-09 |
LUSC | Lung squamous cell carcinoma | 0.246 | 2.31E-08 |
BLCA | Bladder Urothelial Carcinoma | 0.244 | 6.14E-07 |